# Alliance Entertainment Holding Corp: financial statements, quarterly

AENT · Nasdaq · CIK 1823584 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/aent.md) · [Financials](/companies/aent/financials.md) · [Filings](/companies/aent/filings.md) · [Insiders](/companies/aent/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aent/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [227](/filings/0001493152-24-044735.md) | [426](/filings/0001493152-25-006421.md) | [211](/filings/0001641172-25-010841.md) | [237 d](/filings/0001493152-25-012989.md) | [229](/filings/0001493152-25-021893.md) | [394](/filings/0001493152-26-006391.md) | [213](/filings/0001493152-26-023051.md) | [228 d](/filings/0001493152-26-042141.md) | [254](/filings/0001493152-25-021893.md) | [369](/filings/0001493152-26-006391.md) | [258](/filings/0001493152-26-023051.md) | [268 d](/filings/0001493152-26-042141.md) |
| Selling, general and administrative | $m | [14.4](/filings/0001493152-24-044735.md) | [15.2](/filings/0001493152-25-006421.md) | [13.9](/filings/0001641172-25-010841.md) | [14.0 d](/filings/0001493152-25-012989.md) | [13.1](/filings/0001493152-25-021893.md) | [13.8](/filings/0001493152-26-006391.md) | [14.2](/filings/0001493152-26-023051.md) | [14.9 d](/filings/0001493152-26-042141.md) | [15.1](/filings/0001493152-25-021893.md) | [16.6](/filings/0001493152-26-006391.md) | [16.9](/filings/0001493152-26-023051.md) | [17.6 d](/filings/0001493152-26-042141.md) |
| Operating income | $m | [(1.6)](/filings/0001493152-24-044735.md) | [16.0](/filings/0001493152-25-006421.md) | [(0.7)](/filings/0001641172-25-010841.md) | [0.5 d](/filings/0001493152-25-012989.md) | [2.1](/filings/0001493152-25-021893.md) | [14.8](/filings/0001493152-26-006391.md) | [3.5](/filings/0001493152-26-023051.md) | [9.7 d](/filings/0001493152-26-042141.md) | [10.5](/filings/0001493152-25-021893.md) | [17.3](/filings/0001493152-26-006391.md) | [3.3](/filings/0001493152-26-023051.md) | [(3.9) d](/filings/0001493152-26-042141.md) |
| Interest expense | $m | [2.6](/filings/0001493152-24-044735.md) | [3.0](/filings/0001493152-25-006421.md) | [2.3](/filings/0001641172-25-010841.md) | [3.5 d](/filings/0001493152-25-012989.md) | [2.8](/filings/0001493152-25-021893.md) | [2.0](/filings/0001493152-26-006391.md) | [1.5](/filings/0001493152-26-023051.md) | [1.6 d](/filings/0001493152-26-042141.md) | [1.6](/filings/0001493152-25-021893.md) | [1.7](/filings/0001493152-26-006391.md) | [1.5](/filings/0001493152-26-023051.md) | [0.2 d](/filings/0001493152-26-042141.md) |
| Income tax | $m | [(1.3)](/filings/0001493152-24-044735.md) | [3.8](/filings/0001493152-25-006421.md) | [(0.5)](/filings/0001641172-25-010841.md) | [(4.8) d](/filings/0001493152-25-012989.md) | [(1.2)](/filings/0001493152-25-021893.md) | [2.4](/filings/0001493152-26-006391.md) | [0.9](/filings/0001493152-26-023051.md) | [1.5 d](/filings/0001493152-26-042141.md) | [1.9](/filings/0001493152-25-021893.md) | [3.6](/filings/0001493152-26-006391.md) | [0.3](/filings/0001493152-26-023051.md) | [(0.0) d](/filings/0001493152-26-042141.md) |
| Net income | $m | [(3.5)](/filings/0001641172-25-010841.md) | [8.9](/filings/0001641172-25-010841.md) | [(3.4)](/filings/0001641172-25-010841.md) | [2.5 d](/filings/0001493152-25-012989.md) | [0.4](/filings/0001493152-26-023051.md) | [7.1](/filings/0001493152-26-023051.md) | [1.9](/filings/0001493152-26-023051.md) | [5.8 d](/filings/0001493152-26-042141.md) | [4.9](/filings/0001493152-26-023051.md) | [9.4](/filings/0001493152-26-023051.md) | [2.3](/filings/0001493152-26-023051.md) | [(3.5) d](/filings/0001493152-26-042141.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001493152-24-044735.md) | [0.18](/filings/0001493152-25-006421.md) | [(0.07)](/filings/0001641172-25-010841.md) | not reported | [0.01](/filings/0001493152-25-021893.md) | [0.14](/filings/0001493152-26-006391.md) | [0.04](/filings/0001493152-26-023051.md) | not reported | [0.10](/filings/0001493152-25-021893.md) | [0.18](/filings/0001493152-26-006391.md) | [0.05](/filings/0001493152-26-023051.md) | not reported |
| Basic EPS | $ per share | [(0.07)](/filings/0001493152-24-044735.md) | [0.18](/filings/0001493152-25-006421.md) | [(0.07)](/filings/0001641172-25-010841.md) | not reported | [0.01](/filings/0001493152-25-021893.md) | [0.14](/filings/0001493152-26-006391.md) | [0.04](/filings/0001493152-26-023051.md) | not reported | [0.10](/filings/0001493152-25-021893.md) | [0.18](/filings/0001493152-26-006391.md) | [0.05](/filings/0001493152-26-023051.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.2](/filings/0001410578-23-002295.md) | [2.7](/filings/0001410578-24-000022.md) | [1.6](/filings/0001410578-24-000692.md) | [1.1](/filings/0001493152-24-044735.md) | [4.3](/filings/0001493152-24-044735.md) | [2.5](/filings/0001493152-25-006421.md) | [2.0](/filings/0001641172-25-010841.md) | [1.2](/filings/0001493152-26-042141.md) | [3.2](/filings/0001493152-25-021893.md) | [1.4](/filings/0001493152-26-006391.md) | [1.2](/filings/0001493152-26-023051.md) | [0.8](/filings/0001493152-26-042141.md) |
| Current assets | $m | [261](/filings/0001410578-23-002295.md) | [307](/filings/0001410578-24-000022.md) | [203](/filings/0001410578-24-000692.md) | [196](/filings/0001493152-25-012989.md) | [252](/filings/0001493152-24-044735.md) | [254](/filings/0001493152-25-006421.md) | [201](/filings/0001641172-25-010841.md) | [218](/filings/0001493152-26-042141.md) | [242](/filings/0001493152-25-021893.md) | [287](/filings/0001493152-26-006391.md) | [240](/filings/0001493152-26-023051.md) | [248](/filings/0001493152-26-042141.md) |
| Total assets | $m | [389](/filings/0001410578-23-002295.md) | [428](/filings/0001410578-24-000022.md) | [324](/filings/0001410578-24-000692.md) | [341](/filings/0001493152-25-012989.md) | [396](/filings/0001493152-24-044735.md) | [402](/filings/0001493152-25-006421.md) | [349](/filings/0001641172-25-010841.md) | [361](/filings/0001493152-26-042141.md) | [383](/filings/0001493152-25-021893.md) | [434](/filings/0001493152-26-006391.md) | [387](/filings/0001493152-26-023051.md) | [398](/filings/0001493152-26-042141.md) |
| Current liabilities | $m | [303](/filings/0001410578-23-002295.md) | [227](/filings/0001410578-24-000022.md) | [145](/filings/0001410578-24-000692.md) | [148](/filings/0001493152-25-012989.md) | [188](/filings/0001493152-24-044735.md) | [204](/filings/0001493152-25-006421.md) | [155](/filings/0001641172-25-010841.md) | [173](/filings/0001493152-26-042141.md) | [189](/filings/0001493152-25-021893.md) | [213](/filings/0001493152-26-006391.md) | [180](/filings/0001493152-26-023051.md) | [186](/filings/0001493152-26-042141.md) |
| Total liabilities | $m | [310](/filings/0001410578-23-002295.md) | [340](/filings/0001410578-24-000022.md) | [239](/filings/0001410578-24-000692.md) | [253](/filings/0001493152-25-012989.md) | [308](/filings/0001493152-24-044735.md) | [306](/filings/0001493152-25-006421.md) | [252](/filings/0001641172-25-010841.md) | [258](/filings/0001493152-26-042141.md) | [275](/filings/0001493152-25-021893.md) | [316](/filings/0001493152-26-006391.md) | [267](/filings/0001493152-26-023051.md) | [281](/filings/0001493152-26-042141.md) |
| Current portion of debt | $m | [126](/filings/0001410578-23-002295.md) | not reported | not reported | [73.0](/filings/0001493152-24-037185.md) | [88.0](/filings/0001493152-24-044735.md) | [70.0](/filings/0001493152-25-006421.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [78.7](/filings/0001641172-25-010841.md) | [88.5](/filings/0001641172-25-010841.md) | [85.1](/filings/0001641172-25-010841.md) | [87.6](/filings/0001493152-26-042141.md) | [88.0](/filings/0001493152-26-023051.md) | [95.6](/filings/0001493152-26-023051.md) | [97.4](/filings/0001493152-26-023051.md) | [103](/filings/0001493152-26-042141.md) | [108](/filings/0001493152-26-023051.md) | [118](/filings/0001493152-26-023051.md) | [120](/filings/0001493152-26-023051.md) | [117](/filings/0001493152-26-042141.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.7)](/filings/0001493152-24-044735.md) | [28.8 d](/filings/0001493152-25-006421.md) | [20.0 d](/filings/0001641172-25-010841.md) | [9.7 d](/filings/0001493152-25-012989.md) | [(11.6)](/filings/0001493152-25-021893.md) | [25.3 d](/filings/0001493152-26-006391.md) | [2.5 d](/filings/0001493152-26-023051.md) | [10.7 d](/filings/0001493152-26-042141.md) | [2.7](/filings/0001493152-25-021893.md) | [(16.5) d](/filings/0001493152-26-006391.md) | [21.1 d](/filings/0001493152-26-023051.md) | [(9.0) d](/filings/0001493152-26-042141.md) |
| Capital expenditure | $m | not reported | not reported | [0.1 d](/filings/0001641172-25-010841.md) | [(0.0) d](/filings/0001493152-25-012989.md) | [0.0](/filings/0001493152-25-021893.md) | [0.0 d](/filings/0001493152-26-006391.md) | [0.0 d](/filings/0001493152-26-023051.md) | [0.0 d](/filings/0001493152-26-042141.md) | [0.3](/filings/0001493152-25-021893.md) | [0.4 d](/filings/0001493152-26-006391.md) | [0.3 d](/filings/0001493152-26-023051.md) | [0.1 d](/filings/0001493152-26-042141.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.5](/filings/0001410578-23-002295.md) | [47.5](/filings/0001410578-24-000022.md) | [48.4](/filings/0001410578-24-000692.md) | [50.5](/filings/0001493152-24-044735.md) | [51.4](/filings/0001493152-25-006421.md) | [50.9](/filings/0001641172-25-010841.md) | [51.0](/filings/0001493152-25-021893.md) | [51.0](/filings/0001493152-26-006391.md) | [51.0](/filings/0001493152-26-023051.md) | [51.0](/filings/0001493152-25-021893.md) | [51.0](/filings/0001493152-26-006391.md) | [51.0](/filings/0001493152-26-023051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,930,770 at 2024-05-09, from the cover of the [10-Q filed 2024-05-09](/filings/0001410578-24-000692.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.